The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Oligonucleotides Market Research Report 2025
Synopsis
The global market for Oligonucleotides was valued at US$ 1518 million in the year 2024 and is projected to reach a revised size of US$ 2950 million by 2031, growing at a CAGR of 10.1% during the forecast period.
Oligonucleotides are short nucleic acid polymers used in research, genetic testing and forensics.
Oligonucleotides are usually made up of 13 to 25 nucleotides and are designed to hybridize specifically to DNA or RNA sequences. Solid-phase clinical synthesis is used to manufacture these small bits of nucleic acid for use in polymerase chain reaction (PCR), DNA sequencing, library construction and artificial gene synthesis.
Global Oligonucleotides key players include Integrated DNA Technologies, Agilent, Sigma-aldrich, Eurofins Genomics, L.G.C Biosearch Technologies, etc. Global top five manufacturers hold a share over 45%.
North America is the largest market, with a share over 35%, followed by Europe and China, both have a share over 35percent.
In terms of product, DNA Oligos is the largest segment, with a share over 65%. And in terms of application, the largest application is Research, followed by Pharmaceutical.
This report aims to provide a comprehensive presentation of the global market for Oligonucleotides, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oligonucleotides.
The Oligonucleotides market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Oligonucleotides market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oligonucleotides companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Integrated DNA Technologies
Agilent
Sigma-aldrich
Eurofins Genomics
L.G.C Biosearch Technologies
Eurogentec S.A
Nitto Denko Avecia Inc
GenScript
BBI Life Sciences
GeneDesign
TriLink BioTechnologies
SGS DNA
LC Sciences
Twist Bioscience
Creative Biogene
General Biosystems
Segment by Type
DNA Oligos
RNA Oligos
Segment by Application
Pharmaceutical
Research
Diagnostic
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oligonucleotides company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global market for Oligonucleotides was valued at US$ 1518 million in the year 2024 and is projected to reach a revised size of US$ 2950 million by 2031, growing at a CAGR of 10.1% during the forecast period.
Oligonucleotides are short nucleic acid polymers used in research, genetic testing and forensics.
Oligonucleotides are usually made up of 13 to 25 nucleotides and are designed to hybridize specifically to DNA or RNA sequences. Solid-phase clinical synthesis is used to manufacture these small bits of nucleic acid for use in polymerase chain reaction (PCR), DNA sequencing, library construction and artificial gene synthesis.
Global Oligonucleotides key players include Integrated DNA Technologies, Agilent, Sigma-aldrich, Eurofins Genomics, L.G.C Biosearch Technologies, etc. Global top five manufacturers hold a share over 45%.
North America is the largest market, with a share over 35%, followed by Europe and China, both have a share over 35percent.
In terms of product, DNA Oligos is the largest segment, with a share over 65%. And in terms of application, the largest application is Research, followed by Pharmaceutical.
This report aims to provide a comprehensive presentation of the global market for Oligonucleotides, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oligonucleotides.
The Oligonucleotides market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Oligonucleotides market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oligonucleotides companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Integrated DNA Technologies
Agilent
Sigma-aldrich
Eurofins Genomics
L.G.C Biosearch Technologies
Eurogentec S.A
Nitto Denko Avecia Inc
GenScript
BBI Life Sciences
GeneDesign
TriLink BioTechnologies
SGS DNA
LC Sciences
Twist Bioscience
Creative Biogene
General Biosystems
Segment by Type
DNA Oligos
RNA Oligos
Segment by Application
Pharmaceutical
Research
Diagnostic
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oligonucleotides company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oligonucleotides Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 DNA Oligos
1.2.3 RNA Oligos
1.3 Market by Application
1.3.1 Global Oligonucleotides Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical
1.3.3 Research
1.3.4 Diagnostic
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oligonucleotides Market Perspective (2020-2031)
2.2 Global Oligonucleotides Growth Trends by Region
2.2.1 Global Oligonucleotides Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Oligonucleotides Historic Market Size by Region (2020-2025)
2.2.3 Oligonucleotides Forecasted Market Size by Region (2026-2031)
2.3 Oligonucleotides Market Dynamics
2.3.1 Oligonucleotides Industry Trends
2.3.2 Oligonucleotides Market Drivers
2.3.3 Oligonucleotides Market Challenges
2.3.4 Oligonucleotides Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oligonucleotides Players by Revenue
3.1.1 Global Top Oligonucleotides Players by Revenue (2020-2025)
3.1.2 Global Oligonucleotides Revenue Market Share by Players (2020-2025)
3.2 Global Oligonucleotides Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Oligonucleotides Revenue
3.4 Global Oligonucleotides Market Concentration Ratio
3.4.1 Global Oligonucleotides Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oligonucleotides Revenue in 2024
3.5 Global Key Players of Oligonucleotides Head office and Area Served
3.6 Global Key Players of Oligonucleotides, Product and Application
3.7 Global Key Players of Oligonucleotides, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Oligonucleotides Breakdown Data by Type
4.1 Global Oligonucleotides Historic Market Size by Type (2020-2025)
4.2 Global Oligonucleotides Forecasted Market Size by Type (2026-2031)
5 Oligonucleotides Breakdown Data by Application
5.1 Global Oligonucleotides Historic Market Size by Application (2020-2025)
5.2 Global Oligonucleotides Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Oligonucleotides Market Size (2020-2031)
6.2 North America Oligonucleotides Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Oligonucleotides Market Size by Country (2020-2025)
6.4 North America Oligonucleotides Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Oligonucleotides Market Size (2020-2031)
7.2 Europe Oligonucleotides Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Oligonucleotides Market Size by Country (2020-2025)
7.4 Europe Oligonucleotides Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Oligonucleotides Market Size (2020-2031)
8.2 Asia-Pacific Oligonucleotides Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Oligonucleotides Market Size by Region (2020-2025)
8.4 Asia-Pacific Oligonucleotides Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Oligonucleotides Market Size (2020-2031)
9.2 Latin America Oligonucleotides Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Oligonucleotides Market Size by Country (2020-2025)
9.4 Latin America Oligonucleotides Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oligonucleotides Market Size (2020-2031)
10.2 Middle East & Africa Oligonucleotides Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Oligonucleotides Market Size by Country (2020-2025)
10.4 Middle East & Africa Oligonucleotides Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Integrated DNA Technologies
11.1.1 Integrated DNA Technologies Company Details
11.1.2 Integrated DNA Technologies Business Overview
11.1.3 Integrated DNA Technologies Oligonucleotides Introduction
11.1.4 Integrated DNA Technologies Revenue in Oligonucleotides Business (2020-2025)
11.1.5 Integrated DNA Technologies Recent Development
11.2 Agilent
11.2.1 Agilent Company Details
11.2.2 Agilent Business Overview
11.2.3 Agilent Oligonucleotides Introduction
11.2.4 Agilent Revenue in Oligonucleotides Business (2020-2025)
11.2.5 Agilent Recent Development
11.3 Sigma-aldrich
11.3.1 Sigma-aldrich Company Details
11.3.2 Sigma-aldrich Business Overview
11.3.3 Sigma-aldrich Oligonucleotides Introduction
11.3.4 Sigma-aldrich Revenue in Oligonucleotides Business (2020-2025)
11.3.5 Sigma-aldrich Recent Development
11.4 Eurofins Genomics
11.4.1 Eurofins Genomics Company Details
11.4.2 Eurofins Genomics Business Overview
11.4.3 Eurofins Genomics Oligonucleotides Introduction
11.4.4 Eurofins Genomics Revenue in Oligonucleotides Business (2020-2025)
11.4.5 Eurofins Genomics Recent Development
11.5 L.G.C Biosearch Technologies
11.5.1 L.G.C Biosearch Technologies Company Details
11.5.2 L.G.C Biosearch Technologies Business Overview
11.5.3 L.G.C Biosearch Technologies Oligonucleotides Introduction
11.5.4 L.G.C Biosearch Technologies Revenue in Oligonucleotides Business (2020-2025)
11.5.5 L.G.C Biosearch Technologies Recent Development
11.6 Eurogentec S.A
11.6.1 Eurogentec S.A Company Details
11.6.2 Eurogentec S.A Business Overview
11.6.3 Eurogentec S.A Oligonucleotides Introduction
11.6.4 Eurogentec S.A Revenue in Oligonucleotides Business (2020-2025)
11.6.5 Eurogentec S.A Recent Development
11.7 Nitto Denko Avecia Inc
11.7.1 Nitto Denko Avecia Inc Company Details
11.7.2 Nitto Denko Avecia Inc Business Overview
11.7.3 Nitto Denko Avecia Inc Oligonucleotides Introduction
11.7.4 Nitto Denko Avecia Inc Revenue in Oligonucleotides Business (2020-2025)
11.7.5 Nitto Denko Avecia Inc Recent Development
11.8 GenScript
11.8.1 GenScript Company Details
11.8.2 GenScript Business Overview
11.8.3 GenScript Oligonucleotides Introduction
11.8.4 GenScript Revenue in Oligonucleotides Business (2020-2025)
11.8.5 GenScript Recent Development
11.9 BBI Life Sciences
11.9.1 BBI Life Sciences Company Details
11.9.2 BBI Life Sciences Business Overview
11.9.3 BBI Life Sciences Oligonucleotides Introduction
11.9.4 BBI Life Sciences Revenue in Oligonucleotides Business (2020-2025)
11.9.5 BBI Life Sciences Recent Development
11.10 GeneDesign
11.10.1 GeneDesign Company Details
11.10.2 GeneDesign Business Overview
11.10.3 GeneDesign Oligonucleotides Introduction
11.10.4 GeneDesign Revenue in Oligonucleotides Business (2020-2025)
11.10.5 GeneDesign Recent Development
11.11 TriLink BioTechnologies
11.11.1 TriLink BioTechnologies Company Details
11.11.2 TriLink BioTechnologies Business Overview
11.11.3 TriLink BioTechnologies Oligonucleotides Introduction
11.11.4 TriLink BioTechnologies Revenue in Oligonucleotides Business (2020-2025)
11.11.5 TriLink BioTechnologies Recent Development
11.12 SGS DNA
11.12.1 SGS DNA Company Details
11.12.2 SGS DNA Business Overview
11.12.3 SGS DNA Oligonucleotides Introduction
11.12.4 SGS DNA Revenue in Oligonucleotides Business (2020-2025)
11.12.5 SGS DNA Recent Development
11.13 LC Sciences
11.13.1 LC Sciences Company Details
11.13.2 LC Sciences Business Overview
11.13.3 LC Sciences Oligonucleotides Introduction
11.13.4 LC Sciences Revenue in Oligonucleotides Business (2020-2025)
11.13.5 LC Sciences Recent Development
11.14 Twist Bioscience
11.14.1 Twist Bioscience Company Details
11.14.2 Twist Bioscience Business Overview
11.14.3 Twist Bioscience Oligonucleotides Introduction
11.14.4 Twist Bioscience Revenue in Oligonucleotides Business (2020-2025)
11.14.5 Twist Bioscience Recent Development
11.15 Creative Biogene
11.15.1 Creative Biogene Company Details
11.15.2 Creative Biogene Business Overview
11.15.3 Creative Biogene Oligonucleotides Introduction
11.15.4 Creative Biogene Revenue in Oligonucleotides Business (2020-2025)
11.15.5 Creative Biogene Recent Development
11.16 General Biosystems
11.16.1 General Biosystems Company Details
11.16.2 General Biosystems Business Overview
11.16.3 General Biosystems Oligonucleotides Introduction
11.16.4 General Biosystems Revenue in Oligonucleotides Business (2020-2025)
11.16.5 General Biosystems Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of TablesList of Tables
Table 1. Global Oligonucleotides Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of DNA Oligos
Table 3. Key Players of RNA Oligos
Table 4. Global Oligonucleotides Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Oligonucleotides Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Oligonucleotides Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Oligonucleotides Market Share by Region (2020-2025)
Table 8. Global Oligonucleotides Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Oligonucleotides Market Share by Region (2026-2031)
Table 10. Oligonucleotides Market Trends
Table 11. Oligonucleotides Market Drivers
Table 12. Oligonucleotides Market Challenges
Table 13. Oligonucleotides Market Restraints
Table 14. Global Oligonucleotides Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Oligonucleotides Market Share by Players (2020-2025)
Table 16. Global Top Oligonucleotides Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oligonucleotides as of 2024)
Table 17. Ranking of Global Top Oligonucleotides Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Oligonucleotides Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Oligonucleotides, Headquarters and Area Served
Table 20. Global Key Players of Oligonucleotides, Product and Application
Table 21. Global Key Players of Oligonucleotides, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Oligonucleotides Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Oligonucleotides Revenue Market Share by Type (2020-2025)
Table 25. Global Oligonucleotides Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Oligonucleotides Revenue Market Share by Type (2026-2031)
Table 27. Global Oligonucleotides Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Oligonucleotides Revenue Market Share by Application (2020-2025)
Table 29. Global Oligonucleotides Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Oligonucleotides Revenue Market Share by Application (2026-2031)
Table 31. North America Oligonucleotides Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Oligonucleotides Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Oligonucleotides Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Oligonucleotides Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Oligonucleotides Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Oligonucleotides Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Oligonucleotides Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Oligonucleotides Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Oligonucleotides Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Oligonucleotides Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Oligonucleotides Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Oligonucleotides Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Oligonucleotides Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Oligonucleotides Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Oligonucleotides Market Size by Country (2026-2031) & (US$ Million)
Table 46. Integrated DNA Technologies Company Details
Table 47. Integrated DNA Technologies Business Overview
Table 48. Integrated DNA Technologies Oligonucleotides Product
Table 49. Integrated DNA Technologies Revenue in Oligonucleotides Business (2020-2025) & (US$ Million)
Table 50. Integrated DNA Technologies Recent Development
Table 51. Agilent Company Details
Table 52. Agilent Business Overview
Table 53. Agilent Oligonucleotides Product
Table 54. Agilent Revenue in Oligonucleotides Business (2020-2025) & (US$ Million)
Table 55. Agilent Recent Development
Table 56. Sigma-aldrich Company Details
Table 57. Sigma-aldrich Business Overview
Table 58. Sigma-aldrich Oligonucleotides Product
Table 59. Sigma-aldrich Revenue in Oligonucleotides Business (2020-2025) & (US$ Million)
Table 60. Sigma-aldrich Recent Development
Table 61. Eurofins Genomics Company Details
Table 62. Eurofins Genomics Business Overview
Table 63. Eurofins Genomics Oligonucleotides Product
Table 64. Eurofins Genomics Revenue in Oligonucleotides Business (2020-2025) & (US$ Million)
Table 65. Eurofins Genomics Recent Development
Table 66. L.G.C Biosearch Technologies Company Details
Table 67. L.G.C Biosearch Technologies Business Overview
Table 68. L.G.C Biosearch Technologies Oligonucleotides Product
Table 69. L.G.C Biosearch Technologies Revenue in Oligonucleotides Business (2020-2025) & (US$ Million)
Table 70. L.G.C Biosearch Technologies Recent Development
Table 71. Eurogentec S.A Company Details
Table 72. Eurogentec S.A Business Overview
Table 73. Eurogentec S.A Oligonucleotides Product
Table 74. Eurogentec S.A Revenue in Oligonucleotides Business (2020-2025) & (US$ Million)
Table 75. Eurogentec S.A Recent Development
Table 76. Nitto Denko Avecia Inc Company Details
Table 77. Nitto Denko Avecia Inc Business Overview
Table 78. Nitto Denko Avecia Inc Oligonucleotides Product
Table 79. Nitto Denko Avecia Inc Revenue in Oligonucleotides Business (2020-2025) & (US$ Million)
Table 80. Nitto Denko Avecia Inc Recent Development
Table 81. GenScript Company Details
Table 82. GenScript Business Overview
Table 83. GenScript Oligonucleotides Product
Table 84. GenScript Revenue in Oligonucleotides Business (2020-2025) & (US$ Million)
Table 85. GenScript Recent Development
Table 86. BBI Life Sciences Company Details
Table 87. BBI Life Sciences Business Overview
Table 88. BBI Life Sciences Oligonucleotides Product
Table 89. BBI Life Sciences Revenue in Oligonucleotides Business (2020-2025) & (US$ Million)
Table 90. BBI Life Sciences Recent Development
Table 91. GeneDesign Company Details
Table 92. GeneDesign Business Overview
Table 93. GeneDesign Oligonucleotides Product
Table 94. GeneDesign Revenue in Oligonucleotides Business (2020-2025) & (US$ Million)
Table 95. GeneDesign Recent Development
Table 96. TriLink BioTechnologies Company Details
Table 97. TriLink BioTechnologies Business Overview
Table 98. TriLink BioTechnologies Oligonucleotides Product
Table 99. TriLink BioTechnologies Revenue in Oligonucleotides Business (2020-2025) & (US$ Million)
Table 100. TriLink BioTechnologies Recent Development
Table 101. SGS DNA Company Details
Table 102. SGS DNA Business Overview
Table 103. SGS DNA Oligonucleotides Product
Table 104. SGS DNA Revenue in Oligonucleotides Business (2020-2025) & (US$ Million)
Table 105. SGS DNA Recent Development
Table 106. LC Sciences Company Details
Table 107. LC Sciences Business Overview
Table 108. LC Sciences Oligonucleotides Product
Table 109. LC Sciences Revenue in Oligonucleotides Business (2020-2025) & (US$ Million)
Table 110. LC Sciences Recent Development
Table 111. Twist Bioscience Company Details
Table 112. Twist Bioscience Business Overview
Table 113. Twist Bioscience Oligonucleotides Product
Table 114. Twist Bioscience Revenue in Oligonucleotides Business (2020-2025) & (US$ Million)
Table 115. Twist Bioscience Recent Development
Table 116. Creative Biogene Company Details
Table 117. Creative Biogene Business Overview
Table 118. Creative Biogene Oligonucleotides Product
Table 119. Creative Biogene Revenue in Oligonucleotides Business (2020-2025) & (US$ Million)
Table 120. Creative Biogene Recent Development
Table 121. General Biosystems Company Details
Table 122. General Biosystems Business Overview
Table 123. General Biosystems Oligonucleotides Product
Table 124. General Biosystems Revenue in Oligonucleotides Business (2020-2025) & (US$ Million)
Table 125. General Biosystems Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
Table 129. Authors List of This Report
List of Figures
Figure 1. Oligonucleotides Picture
Figure 2. Global Oligonucleotides Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Oligonucleotides Market Share by Type: 2024 VS 2031
Figure 4. DNA Oligos Features
Figure 5. RNA Oligos Features
Figure 6. Global Oligonucleotides Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Oligonucleotides Market Share by Application: 2024 VS 2031
Figure 8. Pharmaceutical Case Studies
Figure 9. Research Case Studies
Figure 10. Diagnostic Case Studies
Figure 11. Oligonucleotides Report Years Considered
Figure 12. Global Oligonucleotides Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Oligonucleotides Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Oligonucleotides Market Share by Region: 2024 VS 2031
Figure 15. Global Oligonucleotides Market Share by Players in 2024
Figure 16. Global Top Oligonucleotides Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oligonucleotides as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Oligonucleotides Revenue in 2024
Figure 18. North America Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Oligonucleotides Market Share by Country (2020-2031)
Figure 20. United States Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Oligonucleotides Market Share by Country (2020-2031)
Figure 24. Germany Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Oligonucleotides Market Share by Region (2020-2031)
Figure 32. China Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Oligonucleotides Market Share by Country (2020-2031)
Figure 40. Mexico Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Oligonucleotides Market Share by Country (2020-2031)
Figure 44. Turkey Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Integrated DNA Technologies Revenue Growth Rate in Oligonucleotides Business (2020-2025)
Figure 48. Agilent Revenue Growth Rate in Oligonucleotides Business (2020-2025)
Figure 49. Sigma-aldrich Revenue Growth Rate in Oligonucleotides Business (2020-2025)
Figure 50. Eurofins Genomics Revenue Growth Rate in Oligonucleotides Business (2020-2025)
Figure 51. L.G.C Biosearch Technologies Revenue Growth Rate in Oligonucleotides Business (2020-2025)
Figure 52. Eurogentec S.A Revenue Growth Rate in Oligonucleotides Business (2020-2025)
Figure 53. Nitto Denko Avecia Inc Revenue Growth Rate in Oligonucleotides Business (2020-2025)
Figure 54. GenScript Revenue Growth Rate in Oligonucleotides Business (2020-2025)
Figure 55. BBI Life Sciences Revenue Growth Rate in Oligonucleotides Business (2020-2025)
Figure 56. GeneDesign Revenue Growth Rate in Oligonucleotides Business (2020-2025)
Figure 57. TriLink BioTechnologies Revenue Growth Rate in Oligonucleotides Business (2020-2025)
Figure 58. SGS DNA Revenue Growth Rate in Oligonucleotides Business (2020-2025)
Figure 59. LC Sciences Revenue Growth Rate in Oligonucleotides Business (2020-2025)
Figure 60. Twist Bioscience Revenue Growth Rate in Oligonucleotides Business (2020-2025)
Figure 61. Creative Biogene Revenue Growth Rate in Oligonucleotides Business (2020-2025)
Figure 62. General Biosystems Revenue Growth Rate in Oligonucleotides Business (2020-2025)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
